Found 5 matching trials
An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
N/AThis is an open-label, expanded access trial designed to provide access to ...
Location
Banner MD Anderson Cancer Center
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
PHASE3This is a Phase 3, open-label, single arm trial designed to evaluate Cretos...
Status
Active Not Recruiting
Location
Urology Centers Alabama
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
PHASE3This is a Phase 3, open-label, randomized trial designed to evaluate the RF...
Status
Active Not Recruiting
Location
Urology Centers of Alabama PC
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
PHASE2This is a Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate th...
Location
Mayo Clinic Arizona
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
PHASE2This study aims to evaluate the efficacy and safety of Cretostimogene in pa...
Location
Peking University First Hospital (First Clinical Medical School of Peking University)